Pursuant to provision of Regulation 74 (5) of the SEBI (Depositories and Participants) Regulations, 2018, Lincoln Pharmaceuticals has submitted the confirmation certificate as received from Link Intime India, Registrar & Share Transfer Agent (RTA) for the Quarter Ended September 30, 2024.
The above information is a part of company’s filings submitted to BSE.